301207 华兰疫苗
已收盘 09-09 15:00:00
资讯
新帖
简况
华兰疫苗（301207）披露新型流感病毒mRNA疫苗获临床试验批准通知书，9月8日股价上涨6.14%
证券之星 · 09-08 17:57
华兰疫苗（301207）披露新型流感病毒mRNA疫苗获临床试验批准通知书，9月8日股价上涨6.14%
华兰疫苗最新公告：新型流感病毒mRNA疫苗获临床试验批准
证券之星 · 09-07 17:45
华兰疫苗最新公告：新型流感病毒mRNA疫苗获临床试验批准
华兰疫苗：受流感病毒流行毒株发生变化的影响
证券之星 · 09-02
华兰疫苗：受流感病毒流行毒株发生变化的影响
华兰疫苗：截至2026年8月共取得流感疫苗批签发16批次
证券之星 · 09-02
华兰疫苗：截至2026年8月共取得流感疫苗批签发16批次
华兰疫苗（301207）2026年中报简析：净利润同比增长75.23%
证券之星 · 08-30
华兰疫苗（301207）2026年中报简析：净利润同比增长75.23%
华兰疫苗(301207)7月20日股东户数2.3万户，较上期增加0.62%
证券之星 · 08-29
华兰疫苗(301207)7月20日股东户数2.3万户，较上期增加0.62%
华兰疫苗（301207）披露召开2026年第一次临时股东会的通知，8月28日股价下跌2.46%
证券之星 · 08-28
华兰疫苗（301207）披露召开2026年第一次临时股东会的通知，8月28日股价下跌2.46%
股市必读：华兰疫苗新发布《关于开立闲置募集资金现金管理专用结算账户的公告》
证券之星 · 08-24
股市必读：华兰疫苗新发布《关于开立闲置募集资金现金管理专用结算账户的公告》
华兰疫苗：截至2026年8月10日，公司股东人数为两万三千余人
证券之星 · 08-21
华兰疫苗：截至2026年8月10日，公司股东人数为两万三千余人
华兰疫苗（301207）披露开立闲置募集资金现金管理专用结算账户公告，8月20日股价上涨15.78%
证券之星 · 08-20
华兰疫苗（301207）披露开立闲置募集资金现金管理专用结算账户公告，8月20日股价上涨15.78%
生物疫苗股全线大涨，康希诺等5股20CM涨停，默沙东莫德纳黑色素瘤疫苗临床试验传捷报
格隆汇 · 08-20
生物疫苗股全线大涨，康希诺等5股20CM涨停，默沙东莫德纳黑色素瘤疫苗临床试验传捷报
华兰生物：公司控股子公司华兰疫苗正在开展新型流感病毒mRNA疫苗的研发工作
证券之星 · 08-10
华兰生物：公司控股子公司华兰疫苗正在开展新型流感病毒mRNA疫苗的研发工作
华兰疫苗(301207)7月20日股东户数2.3万户，较上期减少4.17%
证券之星 · 08-03
华兰疫苗(301207)7月20日股东户数2.3万户，较上期减少4.17%
股市必读：华兰疫苗（301207）6月18日董秘有最新回复
证券之星 · 06-22
股市必读：华兰疫苗（301207）6月18日董秘有最新回复
华兰疫苗：截至2026年6月10日，公司股东人数为两万四千余人
证券之星 · 06-18
华兰疫苗：截至2026年6月10日，公司股东人数为两万四千余人
华兰疫苗最新公告：新型佐剂流感病毒裂解疫苗获临床试验批准
证券之星 · 06-05
华兰疫苗最新公告：新型佐剂流感病毒裂解疫苗获临床试验批准
华兰疫苗：公司目前无汉坦病毒相关疫苗产品
证券之星 · 06-03
华兰疫苗：公司目前无汉坦病毒相关疫苗产品
华兰疫苗：公司在《2025年年度报告》中详细论述了未来战略发展目标
证券之星 · 06-03
华兰疫苗：公司在《2025年年度报告》中详细论述了未来战略发展目标
股市必读：华兰疫苗（301207）6月1日董秘有最新回复
证券之星 · 06-02
股市必读：华兰疫苗（301207）6月1日董秘有最新回复
华兰疫苗：截至2026年5月29日，公司股东人数为两万四千余人
证券之星 · 06-01
华兰疫苗：截至2026年5月29日，公司股东人数为两万四千余人
暂无数据
公司概况
公司名称：
华兰生物疫苗股份有限公司
所属行业：
医药制造业
上市日期：
2022-02-18
主营业务：
华兰生物疫苗股份有限公司的主营业务是人用疫苗研发、生产、销售。公司的主要产品是流感疫苗。
发行价格：
56.88
{"stockData":{"symbol":"301207","market":"SZ","secType":"STK","nameCN":"华兰疫苗","latestPrice":18.16,"timestamp":1788937410000,"preClose":18.49,"halted":0,"volume":8576630,"delay":0,"changeRate":-0.0178,"floatShares":601000000,"shares":601000000,"eps":0.3304,"marketStatus":"已收盘","change":-0.33,"latestTime":"09-09 15:00:00","open":18.31,"high":18.57,"low":18.02,"amount":156000000,"amplitude":0.0297,"askPrice":18.17,"askSize":21,"bidPrice":18.16,"bidSize":125,"shortable":0,"etf":0,"ttmEps":0.3304,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789003800000},"marketStatusCode":5,"adr":0,"adjPreClose":18.49,"symbolType":"stock","openAndCloseTimeList":[[1788917400000,1788924600000],[1788930000000,1788937200000]],"highLimit":20.34,"lowLimit":16.64,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":601027500,"isCdr":false,"pbRate":2.11,"roa":"--","peRate":54.96368,"roe":"0.65%","epsLYR":0.3074,"committee":-0.158568,"marketValue":10915000000,"turnoverRate":0.0143,"status":1,"floatMarketCap":10908000000},"requestUrl":"/m/hq/s/301207/tweets","defaultTab":"tweets","newsList":[{"id":"2665844321","title":"华兰疫苗（301207）披露新型流感病毒mRNA疫苗获临床试验批准通知书，9月8日股价上涨6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665844321","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665844321?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:57","pubTimestamp":1788861456,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，华兰疫苗报收于18.49元，较前一交易日上涨6.14%，最新总市值为111.13亿元。近日，华兰生物疫苗股份有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意其新型流感病毒mRNA疫苗开展临床试验。该疫苗注册分类为预防用生物制品1.2类，适应症为预防由疫苗相关型别的流感病毒引起的流行性感冒。目前国内外多家企业布局流感病毒mRNA疫苗，但国内尚无同类产品获批上市或取得临床试验批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311272","title":"华兰疫苗最新公告：新型流感病毒mRNA疫苗获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311272","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665311272?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:45","pubTimestamp":1788774309,"startTime":"0","endTime":"0","summary":"华兰疫苗(301207.SZ)公告称，公司收到国家药监局核准签发的关于新型流感病毒mRNA疫苗的《药物临床试验批准通知书》，同意开展预防由疫苗相关型别的流感病毒引起的流行性感冒的临床试验。该疫苗采用mRNA技术路线，国内尚无同类产品获批上市，公司成为国内首家取得该疫苗临床试验默示许可的企业。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700022937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664867150","title":"华兰疫苗：受流感病毒流行毒株发生变化的影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2664867150","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664867150?lang=zh_cn&edition=full","pubTime":"2026-09-02 08:54","pubTimestamp":1788310444,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰疫苗(301207)09月01日在投资者关系平台上答复投资者关心的问题。投资者提问：今年各家流感疫苗签发时间较往年至少晚了两个月，公司也是7月底，才首批签发，是什么原因引起的华兰疫苗回复：尊敬的投资者您好！受流感病毒流行毒株发生变化的影响，流感疫苗行业的批签发节奏与上年同期存在一定差异，经查询中检院公示数据，截至2026年8月，公司共取得流感疫苗批签发16批次，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200008223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664153867","title":"华兰疫苗：截至2026年8月共取得流感疫苗批签发16批次","url":"https://stock-news.laohu8.com/highlight/detail?id=2664153867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664153867?lang=zh_cn&edition=full","pubTime":"2026-09-02 08:51","pubTimestamp":1788310306,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰疫苗(301207)09月01日在投资者关系平台上答复投资者关心的问题。投资者提问：目前国内流感疫苗签发量明显少于往年，叠加农村一老一小免费接种流感疫苗，公司产能跟得上需求吗华兰疫苗回复：尊敬的投资者您好！经查询中检院公示数据，截至2026年8月，公司共取得流感疫苗批签发16批次，公司将根据市场需求情况，合理组织产品供应，积极保障市场接种需求。感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200008044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663048707","title":"华兰疫苗（301207）2026年中报简析：净利润同比增长75.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663048707","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663048707?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:33","pubTimestamp":1788042814,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期华兰疫苗发布2026年中报。根据财报显示，华兰疫苗净利润同比增长75.23%。截至本报告期末，公司营业总收入4438.53万元，同比下降25.98%，归母净利润3644.32万元，同比上升75.23%。然而去年的净利率为15.21%，算上全部成本后，公司产品或服务的附加值高。财报体检工具显示：建议关注公司应收账款状况本文数据来源于华兰疫苗2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000003317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012484","title":"华兰疫苗(301207)7月20日股东户数2.3万户，较上期增加0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012484","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012484?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:20","pubTimestamp":1787995238,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华兰疫苗披露，截至2026年7月20日公司股东户数为2.3万户，较6月30日增加141.0户，增幅为0.62%。在生物制品行业个股中，华兰疫苗股东户数低于行业平均水平，截至7月20日，生物制品行业平均股东户数为3.54万户。从股价来看，2026年6月30日至2026年7月20日，华兰疫苗区间涨幅为3.62%，在此期间股东户数增加141.0户，增幅为0.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662909120","title":"华兰疫苗（301207）披露召开2026年第一次临时股东会的通知，8月28日股价下跌2.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662909120","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662909120?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:40","pubTimestamp":1787928056,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，华兰疫苗报收于17.81元，较前一交易日下跌2.46%，最新总市值为107.04亿元。近日，华兰生物疫苗股份有限公司发布《关于召开2026年第一次临时股东会的通知》。公告显示，公司将于2026年9月28日召开2026年第一次临时股东会，会议由董事会召集，现场会议时间为当日13:30，网络投票时间为同日上午9:15至下午15:00。登记时间为2026年9月23日至24日，可通过电子邮件、传真等方式办理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800055489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661245044","title":"股市必读：华兰疫苗新发布《关于开立闲置募集资金现金管理专用结算账户的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2661245044","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661245044?lang=zh_cn&edition=full","pubTime":"2026-08-24 04:35","pubTimestamp":1787517311,"startTime":"0","endTime":"0","summary":"公司公告汇总关于开立闲置募集资金现金管理专用结算账户的公告华兰生物疫苗股份有限公司于2026年2月27日召开第二届董事会第十八次会议，审议通过继续使用不超过人民币10亿元的闲置募集资金进行现金管理，有效期为董事会审议通过之日起12个月内，资金可循环滚动使用。公司近日开立了两个专用结算账户用于闲置募集资金现金管理，账户分别为中国光大银行焦作人民路支行和兴业银行郑州商务外环路支行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400001694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661255537","title":"华兰疫苗：截至2026年8月10日，公司股东人数为两万三千余人","url":"https://stock-news.laohu8.com/highlight/detail?id=2661255537","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661255537?lang=zh_cn&edition=full","pubTime":"2026-08-21 09:03","pubTimestamp":1787274189,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰疫苗(301207)08月20日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截至8月10日公司股东人数是多少，谢谢华兰疫苗回复：尊敬的投资者您好，截至2026年8月10日，公司股东人数为两万三千余人，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100009359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660881238","title":"华兰疫苗（301207）披露开立闲置募集资金现金管理专用结算账户公告，8月20日股价上涨15.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660881238","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660881238?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:08","pubTimestamp":1787234902,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，华兰疫苗报收于20.25元，较前一交易日上涨15.78%，最新总市值为121.71亿元。近日，华兰生物疫苗股份有限公司披露《关于开立闲置募集资金现金管理专用结算账户的公告》。公告显示，公司于2026年2月27日召开第二届董事会第十八次会议，审议通过继续使用不超过人民币10亿元的闲置募集资金进行现金管理，有效期为董事会审议通过之日起12个月内，资金可循环滚动使用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000044809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660727484","title":"生物疫苗股全线大涨，康希诺等5股20CM涨停，默沙东莫德纳黑色素瘤疫苗临床试验传捷报","url":"https://stock-news.laohu8.com/highlight/detail?id=2660727484","media":"格隆汇","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660727484?lang=zh_cn&edition=full","pubTime":"2026-08-20 09:47","pubTimestamp":1787190439,"startTime":"0","endTime":"0","summary":"8月20日，A股市场生物疫苗股全线大涨，其中，百克生物、康希诺、沃森生物、莱美药业、智飞生物20CM涨停，康华生物逼近20CM涨停，康泰生物涨超17%，华兰疫苗涨超10%，德展健康、双鹭药业、海普瑞、海欣股份、万泰生物10CM涨停，金迪克、博晖创新涨超7%，西藏药业、卫光生物、利德曼、冠昊生物、塞力医疗、赛升药业、申联生物、欧林生物涨超6%。消息面上，默沙东与莫德纳周三宣布，联合研发的黑色素瘤皮肤癌疫苗在首次晚期临床试验中取得积极初步结果。\n\n港股频道更多独家策划、专家专栏，免费查阅>>\n\n 责任编辑：栎树","market":"hk","thumbnail":"http://imgcloud.jrjimg.cn/2026/08/cms_20260820094719181.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2026/08/cms_20260820094719181.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/08/20094758182842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1571399168.USD","LU0058720904.USD","LU0265550359.USD","LU1037948541.HKD","LU2023250843.SGD","LU0942090050.USD","BK0239","BK0046","IE0002141913.USD","LU0648001328.SGD","LU1430594728.SGD","MRNX","IE00BSNM7G36.USD","LU1069347547.HKD","LU1941712264.USD","BK4007","LU1934455863.HKD","LU2491049909.HKD","IE00BN8TJ469.HKD","LU2491050071.SGD","LU1066051811.HKD","LU2125154935.USD","BK4532","LU0985320562.USD","LU0823416689.USD","LU1066053197.SGD","LU2125909247.SGD","IE00B2B36J28.USD","LU1064130708.USD","LU1037948897.HKD","LU1929549753.HKD","SG9999013999.USD","PAWZ","BK0196","VHT","LU0124676726.USD","SG9999014567.USD","JDOC","LU1917777945.USD","LU1023059063.AUD","LU1162221912.USD","LU1066051225.USD","LU0098860793.USD","LU2461242641.AUD","LU2112291526.USD","SG9999015341.SGD","IE00BJJMRZ35.SGD","688185","LU0320765646.SGD","BK4568","IE00BLSP4239.USD","FHLC","LU1989771016.USD","GDOC","LU0432979614.USD","06185","LGHT","LU1934455277.USD","LU0234572021.USD","LU2023250504.SGD","BK4533","IE00B4R5TH58.HKD","LU0122379950.USD","TRUH","LU1983299246.USD","IE00BFTCPJ56.SGD","LU2360032135.SGD","LU1116320901.HKD","BK4548","LU0965508806.USD","PPH","LU2361044949.HKD","300122","LU0208291251.USD","LU1974910355.USD","MRNY","LU0859254822.USD","301207","BK4534","LU1989772840.SGD","LU1328615791.USD","IE00BJT1NW94.SGD","IE00B1BXHZ80.USD","SGXZ57979304.SGD","LU0203347892.USD","SG9999001440.SGD","300142","SG9999014542.SGD","IYH","LU2125909593.SGD","LU1699723380.USD","LU2148510915.USD","LU1291159041.SGD","LU2361044865.SGD","LU2468319806.SGD","LU1064131003.USD","LU0965509101.SGD","688276","BK0188","IXJ","LU2433249047.HKD","LU0211331839.USD","LU1057294990.SGD","LU1093756168.USD","SG9999002224.SGD","LU2106854487.HKD","BK4585","LU2324357040.USD","LU0689626769.HKD","SG9999014575.USD","LU2125154778.USD","LU0320765489.SGD","IE0009355771.USD","LU0965509010.AUD","LU1989772923.USD","LU0106261372.USD","SG9999014559.SGD","MRK","BK4559","LU0130102774.USD","WDNA","RXL","LU2361045086.USD","SG9999001176.SGD","BK4139","BK4551","LU1093756325.SGD","LU1941712348.USD","LU0238689110.USD","300006","HRTS","LU0861579265.USD","LU2089984988.USD","LU2357627491.SGD","BK0070","LU1035773651.USD","BK4550","LU1923622614.USD","LU2491050154.USD","BK0077","LU0203345920.USD","LU2580892789.USD","LU0868494708.USD","LU0265550946.USD","BK4516","LU0477156953.USD","LU0868494617.USD","LU0289739699.SGD","GNOM","LU0980610538.SGD","SG9999001176.USD","LU2580892862.HKD","LU1066051498.USD","IE00BBT3K403.USD","IE00BLSP4452.SGD","LU1061106388.HKD","LU1585245621.USD","LU1201861249.SGD","BK4588","SG9999015358.SGD","SG9999002232.USD","IDNA","LU0006306889.USD","XLV","LU0130517989.USD","IHE","FTXH","LU0070302665.USD","MRNA","LU0965509283.SGD","LU0266013472.USD","LU1116320737.USD","IE000M9KFDE8.USD","LU1934455194.USD","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658985749","title":"华兰生物：公司控股子公司华兰疫苗正在开展新型流感病毒mRNA疫苗的研发工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2658985749","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658985749?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:30","pubTimestamp":1786347046,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司是否有研发mRNA流感疫苗？华兰生物回复：您好，公司控股子公司华兰疫苗正在开展新型流感病毒mRNA疫苗的研发工作，疫苗研发存在不确定性，敬请投资者注意投资风险。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000013882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0046","BK0185","002007","BK0028","BK0188","BK0077","BK0197","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656327974","title":"华兰疫苗(301207)7月20日股东户数2.3万户，较上期减少4.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656327974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656327974?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:45","pubTimestamp":1785750317,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华兰疫苗披露，截至2026年7月20日公司股东户数为2.3万户，较6月10日减少1000.0户，减幅为4.17%。在生物制品行业个股中，华兰疫苗股东户数低于行业平均水平，截至7月20日，生物制品行业平均股东户数为3.55万户。从股价来看，2026年6月10日至2026年7月20日，华兰疫苗区间涨幅为2.4%，在此期间股东户数减少1000.0户，减幅为4.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300024122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645019669","title":"股市必读：华兰疫苗（301207）6月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2645019669","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645019669?lang=zh_cn&edition=full","pubTime":"2026-06-22 05:53","pubTimestamp":1782078793,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，华兰疫苗报收于16.48元，上涨0.55%，换手率0.59%，成交量3.56万手，成交额5852.82万元。董秘最新回复投资者： 您好！截至2026年6月10日，公司股东人数为两万四千余人，感谢您对公司的关注。当日关注点交易信息汇总：6月18日主力资金净流入2.1万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200001986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644706272","title":"华兰疫苗：截至2026年6月10日，公司股东人数为两万四千余人","url":"https://stock-news.laohu8.com/highlight/detail?id=2644706272","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644706272?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:51","pubTimestamp":1781772672,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰疫苗(301207)06月18日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截止6月15号，公司股东人数是多少？谢谢！华兰疫苗回复：尊敬的投资者您好！截至2026年6月10日，公司股东人数为两万四千余人，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800029161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641114575","title":"华兰疫苗最新公告：新型佐剂流感病毒裂解疫苗获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2641114575","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641114575?lang=zh_cn&edition=full","pubTime":"2026-06-05 18:11","pubTimestamp":1780654295,"startTime":"0","endTime":"0","summary":"华兰疫苗(301207.SZ)公告称，公司近日收到国家药监局核准签发的关于新型佐剂流感病毒裂解疫苗的《药物临床试验批准通知书》，同意开展预防疫苗相关型别的流感病毒引起的流行性感冒的临床试验。该产品采用流感病毒裂解抗原并引入以角鲨烯为主要成分的佐剂系统，旨在增强老年人等免疫力较弱人群的免疫反应水平。目前国内尚无同类佐剂流感疫苗产品正式获批上市。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500031536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640222989","title":"华兰疫苗：公司目前无汉坦病毒相关疫苗产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2640222989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640222989?lang=zh_cn&edition=full","pubTime":"2026-06-03 09:06","pubTimestamp":1780448768,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰疫苗(301207)06月02日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好请问贵公司有汉坦病毒相关产品吗？华兰疫苗回复：尊敬的投资者您好，公司目前无汉坦病毒相关疫苗产品，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300010294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640224679","title":"华兰疫苗：公司在《2025年年度报告》中详细论述了未来战略发展目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2640224679","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640224679?lang=zh_cn&edition=full","pubTime":"2026-06-03 09:03","pubTimestamp":1780448595,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰疫苗(301207)06月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司新领导层，对华兰疫苗的未来展望是如何描述的？华兰疫苗回复：尊敬的投资者您好，公司在《2025年年度报告》中详细论述了未来战略发展目标，具体内容详见《2025年年度报告》的第三节管理层讨论与分析之“十一、公司未来发展的展望”，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300010237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640969807","title":"股市必读：华兰疫苗（301207）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640969807","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640969807?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:09","pubTimestamp":1780337353,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，华兰疫苗报收于18.21元，上涨1.05%，换手率0.67%，成交量4.01万手，成交额7294.52万元。董秘最新回复投资者： 请问截止5月26日，股东人数多少？截至2026年5月29日，公司股东人数为两万四千余人，感谢您对公司的关注。当日关注点来自交易信息汇总：主力资金6月1日净流出418.56万元，显示主力短期呈离场态势。来自交易信息汇总：散户与游资资金合计净流入422.56万元，反映市场中小资金参与积极性较高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200001684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640934737","title":"华兰疫苗：截至2026年5月29日，公司股东人数为两万四千余人","url":"https://stock-news.laohu8.com/highlight/detail?id=2640934737","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640934737?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:33","pubTimestamp":1780302800,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰疫苗(301207)06月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止5月26日，股东人数多少？华兰疫苗回复：尊敬的投资者您好！截至2026年5月29日，公司股东人数为两万四千余人，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100024378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788948244972,"stockEarnings":[{"period":"1week","weight":0.0554},{"period":"1month","weight":0.0221},{"period":"3month","weight":0.1217},{"period":"6month","weight":-0.0015},{"period":"1year","weight":0.0602},{"period":"ytd","weight":0.0392}],"compareEarnings":[{"period":"1week","weight":-0.0099},{"period":"1month","weight":0.0001},{"period":"3month","weight":-0.0132},{"period":"6month","weight":-0.0457},{"period":"1year","weight":0.0297},{"period":"ytd","weight":-0.0071}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华兰生物疫苗股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"23000人(较上一季度增加0.00%)","perCapita":"26114股","listingDate":"2022-02-18","address":"河南省新乡市红旗区华兰大道甲1号附1号","registeredCapital":"60102万元","survey":" 华兰生物疫苗股份有限公司的主营业务是人用疫苗研发、生产、销售。公司的主要产品是流感疫苗。","listedPrice":56.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华兰疫苗(301207)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华兰疫苗(301207)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华兰疫苗,301207,华兰疫苗股票,华兰疫苗股票老虎,华兰疫苗股票老虎国际,华兰疫苗行情,华兰疫苗股票行情,华兰疫苗股价,华兰疫苗股市,华兰疫苗股票价格,华兰疫苗股票交易,华兰疫苗股票购买,华兰疫苗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华兰疫苗(301207)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华兰疫苗(301207)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}